MOG and neuromyelitis optica: The role of soluble biomarkers extends beyond MS, with evidence increasingly supporting their utility in related disorders such as Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein-Associated Disease (MOGAD).